WED-294 The use of the FibroScan-AST score and AST to pre-identify metabolic dysfunction-associated steatohepatitis patients with active fibrogenesis in a Phase 1b open-label clinical trial

Autor: Noureddin, Mazen, Lawitz, Eric, Alkhouri, Naim, Kayali, Zeid, Rudraraju, Madhavi, Mena, Edward, Loomba, Rohit, Hassanein, Tarek, Mantry, Parvez, Siddiqui, Mohammad, Lucas, Kathryn Jean, Reiss, Garry, Aneiros, Oni, Farno, Dawn, Differding, Shawna, Marshall, Debbie, Biracree, Jaime, Devadas, Bruno, Reddy, Praveena, Patel, Chetna, Tsau, Jennifer, Chen, Michael, Mendoza, Michelle, Butler, Scott, Oakley, Holly, Lichtenberger, Wendi, Hambridge, Shannon, Thakker, Paresh, Wennbo, Haakan, Nagy, Peter, Derdak, Zoltan
Zdroj: In Journal of Hepatology June 2024 80 Supplement 1:S544-S545
Databáze: ScienceDirect
Externí odkaz: